Viewing Study NCT00492505

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:09 AM
Ignite Modification Date: 2026-02-26 @ 2:16 AM
Study NCT ID: NCT00492505
Status: UNKNOWN
Last Update Posted: 2014-01-10
First Post: 2007-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Sponsor: San Diego Pacific Oncology & Hematology Associates
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma (Skin) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIIA melanoma View
None stage IIIB melanoma View
None stage IIIC melanoma View